First-line therapy of CD20+ diffuse large B-cell lymphoma: facts and open questions.
Brusamolino
Ercole
E
D018951:Antigens, CD20; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
D018951:Antigens, CD20